Lifecore Biomedical Inc (NASDAQ: LFCR) is -14.22% lower on its value in year-to-date trading and has touched a low of $3.09 and a high of $11.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LFCR stock was last observed hovering at around $5.17 in the last trading session, with the day’s gains setting it 0.14%.
Currently trading at $5.31, the stock is -23.92% and -26.79% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.16 million and changing 2.71% at the moment leaves the stock -32.19% off its SMA200. LFCR registered 59.94% gain for a year compared to 6-month gain of -29.95%. The firm has a 50-day simple moving average (SMA 50) of $2.48 and a 200-day simple moving average (SMA200) of -$7.76.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -35.64% loss in the last 1 month and extending the period to 3 months gives it a -15.31%, and is 5.36% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.38% over the week and 6.19% over the month.
Lifecore Biomedical Inc (LFCR) has around 459 employees, a market worth around $162.22M and $141.30M in sales. Profit margin for the company is -70.86%. Distance from 52-week low is 72.12% and -53.64% from its 52-week high. The company has generated returns on investments over the last 12 months (-68.64%).
Lifecore Biomedical Inc quarterly earnings per share for the current quarter are estimated at $0 with sales reaching $24.54M over the same period.The EPS is expected to grow by 87.68% this year, but quarterly earnings will post 19.70% year-over-year. Quarterly sales are estimated to shrink -42.60% in year-over-year returns.
97 institutions hold shares in Lifecore Biomedical Inc (LFCR), with institutional investors hold 78.31% of the company’s shares. The shares outstanding are 30.32M, and float is at 29.63M with Short Float at 5.93%. Institutions hold 74.76% of the Float.
The top institutional shareholder in the company is Wynnefield Capital Management LLC with over 4.92 million shares valued at $47.61 million. The investor’s holdings represent 16.24% of the LFCR Shares outstanding. As of Jun 29, 2023, the second largest holder is Legion Partners Asset Management, LLC with 2.94 million shares valued at $28.43 million to account for 9.70% of the shares outstanding. The other top investors are Greenhaven Road Investment Management, L.P. which holds 1.9 million shares representing 6.27% and valued at over $18.4 million, while 22NW, LP holds 5.79% of the shares totaling 1.76 million with a market value of $16.97 million.
